Amdocs Limited Logo

Amdocs Limited

DOX

(3.0)
Stock Price

86,54 USD

15.47% ROA

15.66% ROE

20.04x PER

Market Cap.

10.730.584.350,00 USD

22.91% DER

1.9% Yield

11.3% NPM

Amdocs Limited Stock Analysis

Amdocs Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Amdocs Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (15.92%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a minimal amount of debt (22%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Dividend Growth

The company has demonstrated exceptional dividend growth over the past five years, consistently increasing payouts to shareholders year after year.

5 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

6 PBV

The stock's PBV ratio (2.74x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

7 Buffet Intrinsic Value

The company's stock seems undervalued (756) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

8 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

10 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

11 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

Amdocs Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Amdocs Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Amdocs Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Amdocs Limited Revenue
Year Revenue Growth
1997 290.100.000
1998 403.800.000 28.16%
1999 626.900.000 35.59%
2000 1.118.320.000 43.94%
2001 1.533.910.000 27.09%
2002 1.613.565.000 4.94%
2003 1.483.327.000 -8.78%
2004 1.773.732.000 16.37%
2005 2.038.621.000 12.99%
2006 2.480.050.000 17.8%
2007 2.836.173.000 12.56%
2008 3.162.096.000 10.31%
2009 2.862.607.000 -10.46%
2010 2.984.223.000 4.08%
2011 3.177.728.000 6.09%
2012 3.246.903.000 2.13%
2013 3.345.854.000 2.96%
2014 3.563.637.000 6.11%
2015 3.643.538.000 2.19%
2016 3.718.229.000 2.01%
2017 3.867.155.000 3.85%
2018 3.974.837.000 2.71%
2019 4.086.669.000 2.74%
2020 4.169.039.000 1.98%
2021 4.288.640.000 2.79%
2022 4.576.697.000 6.29%
2023 4.970.256.000 7.92%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Amdocs Limited Research and Development Expenses
Year Research and Development Expenses Growth
1997 17.400.000
1998 25.600.000 32.03%
1999 40.900.000 37.41%
2000 74.852.000 45.36%
2001 105.807.000 29.26%
2002 124.082.000 14.73%
2003 119.256.000 -4.05%
2004 126.407.000 5.66%
2005 144.457.000 12.5%
2006 186.760.000 22.65%
2007 230.444.000 18.96%
2008 225.492.000 -2.2%
2009 210.387.000 -7.18%
2010 207.836.000 -1.23%
2011 221.886.000 6.33%
2012 242.063.000 8.34%
2013 240.266.000 -0.75%
2014 257.896.000 6.84%
2015 254.944.000 -1.16%
2016 252.292.000 -1.05%
2017 259.097.000 2.63%
2018 276.615.000 6.33%
2019 273.936.000 -0.98%
2020 282.042.000 2.87%
2021 312.941.000 9.87%
2022 354.706.000 11.77%
2023 390.772.000 9.23%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Amdocs Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
1997 0
1998 51.200.000 100%
1999 75.700.000 32.36%
2000 137.004.000 44.75%
2001 195.592.000 29.95%
2002 223.551.000 12.51%
2003 206.265.000 -8.38%
2004 210.384.000 1.96%
2005 232.066.000 9.34%
2006 313.997.000 26.09%
2007 370.194.000 15.18%
2008 404.134.000 8.4%
2009 344.335.000 -17.37%
2010 373.585.000 7.83%
2011 409.465.000 8.76%
2012 424.671.000 3.58%
2013 418.574.000 -1.46%
2014 445.134.000 5.97%
2015 440.085.000 -1.15%
2016 464.883.000 5.33%
2017 472.778.000 1.67%
2018 481.093.000 1.73%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Amdocs Limited EBITDA
Year EBITDA Growth
1997 90.500.000
1998 114.000.000 20.61%
1999 177.600.000 35.81%
2000 294.366.000 39.67%
2001 443.984.000 33.7%
2002 458.796.000 3.23%
2003 336.444.000 -36.37%
2004 397.248.000 15.31%
2005 461.814.000 13.98%
2006 505.270.000 8.6%
2007 527.981.000 4.3%
2008 650.437.000 18.83%
2009 606.998.000 -7.16%
2010 606.373.000 -0.1%
2011 585.841.000 -3.5%
2012 602.086.000 2.7%
2013 622.328.000 3.25%
2014 658.420.000 5.48%
2015 716.743.000 8.14%
2016 694.932.000 -3.14%
2017 732.218.000 5.09%
2018 805.815.000 9.13%
2019 775.518.000 -3.91%
2020 793.167.000 2.23%
2021 581.113.000 -36.49%
2022 889.332.000 34.66%
2023 930.316.000 4.41%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Amdocs Limited Gross Profit
Year Gross Profit Growth
1997 121.100.000
1998 161.700.000 25.11%
1999 263.600.000 38.66%
2000 472.796.000 44.25%
2001 680.668.000 30.54%
2002 680.228.000 -0.06%
2003 569.968.000 -19.34%
2004 650.900.000 12.43%
2005 742.966.000 12.39%
2006 896.224.000 17.1%
2007 1.039.791.000 13.81%
2008 1.135.805.000 8.45%
2009 1.027.974.000 -10.49%
2010 1.078.557.000 4.69%
2011 1.108.361.000 2.69%
2012 1.161.435.000 4.57%
2013 1.178.802.000 1.47%
2014 1.256.745.000 6.2%
2015 1.294.050.000 2.88%
2016 1.310.189.000 1.23%
2017 1.359.499.000 3.63%
2018 1.379.561.000 1.45%
2019 1.433.497.000 3.76%
2020 1.413.476.000 -1.42%
2021 1.477.673.000 4.34%
2022 1.619.150.000 8.74%
2023 1.755.856.000 7.79%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Amdocs Limited Net Profit
Year Net Profit Growth
1997 5.900.000
1998 30.100.000 80.4%
1999 98.500.000 69.44%
2000 5.978.000 -1547.71%
2001 66.386.000 91%
2002 -5.061.000 1411.72%
2003 168.883.000 103%
2004 234.860.000 28.09%
2005 288.636.000 18.63%
2006 318.636.000 9.42%
2007 364.937.000 12.69%
2008 378.906.000 3.69%
2009 326.176.000 -16.17%
2010 343.906.000 5.16%
2011 346.665.000 0.8%
2012 391.371.000 11.42%
2013 412.439.000 5.11%
2014 422.122.000 2.29%
2015 446.163.000 5.39%
2016 409.331.000 -9%
2017 436.826.000 6.29%
2018 354.396.000 -23.26%
2019 479.446.000 26.08%
2020 497.840.000 3.69%
2021 688.374.000 27.68%
2022 549.501.000 -25.27%
2023 408.044.000 -34.67%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Amdocs Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1997 0
1998 0 0%
1999 1 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 1 0%
2004 1 100%
2005 1 0%
2006 2 0%
2007 2 0%
2008 2 0%
2009 2 0%
2010 2 0%
2011 2 0%
2012 2 50%
2013 3 0%
2014 3 0%
2015 3 0%
2016 3 0%
2017 3 0%
2018 2 0%
2019 3 33.33%
2020 4 0%
2021 5 40%
2022 4 -25%
2023 3 -33.33%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Amdocs Limited Free Cashflow
Year Free Cashflow Growth
1997 -23.200.000
1998 39.900.000 158.15%
1999 110.100.000 63.76%
2000 231.017.000 52.34%
2001 246.096.000 6.13%
2002 353.714.000 30.43%
2003 319.561.000 -10.69%
2004 290.256.000 -10.1%
2005 310.377.000 6.48%
2006 348.503.000 10.94%
2007 257.569.000 -35.3%
2008 347.798.000 25.94%
2009 435.831.000 20.2%
2010 598.253.000 27.15%
2011 425.713.000 -40.53%
2012 392.016.000 -8.6%
2013 563.823.000 30.47%
2014 597.689.000 5.67%
2015 652.119.000 8.35%
2016 490.148.000 -33.05%
2017 502.720.000 2.5%
2018 326.103.000 -54.16%
2019 528.291.000 38.27%
2020 452.626.000 -16.72%
2021 715.369.000 36.73%
2022 529.500.000 -35.1%
2023 245.814.000 -115.41%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Amdocs Limited Operating Cashflow
Year Operating Cashflow Growth
1997 25.900.000
1998 66.500.000 61.05%
1999 152.300.000 56.34%
2000 287.588.000 47.04%
2001 337.987.000 14.91%
2002 412.276.000 18.02%
2003 381.971.000 -7.93%
2004 344.404.000 -10.91%
2005 381.751.000 9.78%
2006 429.220.000 11.06%
2007 423.995.000 -1.23%
2008 483.621.000 12.33%
2009 519.156.000 6.84%
2010 685.198.000 24.23%
2011 535.492.000 -27.96%
2012 514.069.000 -4.17%
2013 670.547.000 23.34%
2014 709.258.000 5.46%
2015 772.622.000 8.2%
2016 620.234.000 -24.57%
2017 636.112.000 2.5%
2018 557.249.000 -14.15%
2019 656.377.000 15.1%
2020 658.136.000 0.27%
2021 925.807.000 28.91%
2022 756.719.000 -22.34%
2023 272.371.000 -177.83%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Amdocs Limited Capital Expenditure
Year Capital Expenditure Growth
1997 49.100.000
1998 26.600.000 -84.59%
1999 42.200.000 36.97%
2000 56.571.000 25.4%
2001 91.891.000 38.44%
2002 58.562.000 -56.91%
2003 62.410.000 6.17%
2004 54.148.000 -15.26%
2005 71.374.000 24.13%
2006 80.717.000 11.58%
2007 166.426.000 51.5%
2008 135.823.000 -22.53%
2009 83.325.000 -63%
2010 86.945.000 4.16%
2011 109.779.000 20.8%
2012 122.053.000 10.06%
2013 106.724.000 -14.36%
2014 111.569.000 4.34%
2015 120.503.000 7.41%
2016 130.086.000 7.37%
2017 133.392.000 2.48%
2018 231.146.000 42.29%
2019 128.086.000 -80.46%
2020 205.510.000 37.67%
2021 210.438.000 2.34%
2022 227.219.000 7.39%
2023 26.557.000 -755.59%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Amdocs Limited Equity
Year Equity Growth
1997 94.300.000
1998 -21.900.000 530.59%
1999 123.700.000 117.7%
2000 1.430.772.000 91.35%
2001 1.512.091.000 5.38%
2002 1.416.275.000 -6.77%
2003 1.591.600.000 11.02%
2004 1.444.190.000 -10.21%
2005 1.656.452.000 12.81%
2006 2.154.165.000 23.1%
2007 2.600.243.000 17.16%
2008 2.805.191.000 7.31%
2009 3.213.053.000 12.69%
2010 3.229.380.000 0.51%
2011 3.023.301.000 -6.82%
2012 3.033.202.000 0.33%
2013 3.274.783.000 7.38%
2014 3.395.836.000 3.56%
2015 3.406.842.000 0.32%
2016 3.453.561.000 1.35%
2017 3.574.070.000 3.37%
2018 3.492.042.000 -2.35%
2019 3.542.466.000 1.42%
2020 3.665.155.000 3.35%
2021 3.635.184.000 -0.82%
2022 3.560.278.000 -2.1%
2023 3.566.932.000 0.19%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Amdocs Limited Assets
Year Assets Growth
1997 220.600.000
1998 240.000.000 8.08%
1999 430.000.000 44.19%
2000 1.935.085.000 77.78%
2001 2.624.436.000 26.27%
2002 2.540.094.000 -3.32%
2003 2.877.517.000 11.73%
2004 2.863.884.000 -0.48%
2005 3.202.468.000 10.57%
2006 3.962.828.000 19.19%
2007 4.344.599.000 8.79%
2008 4.579.063.000 5.12%
2009 4.328.417.000 -5.79%
2010 4.820.604.000 10.21%
2011 4.636.572.000 -3.97%
2012 4.645.223.000 0.19%
2013 4.925.813.000 5.7%
2014 5.185.277.000 5%
2015 5.324.652.000 2.62%
2016 5.331.355.000 0.13%
2017 5.279.380.000 -0.98%
2018 5.347.815.000 1.28%
2019 5.292.826.000 -1.04%
2020 6.341.621.000 16.54%
2021 6.511.774.000 2.61%
2022 6.390.393.000 -1.9%
2023 6.425.653.000 0.55%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Amdocs Limited Liabilities
Year Liabilities Growth
1997 126.300.000
1998 261.900.000 51.78%
1999 306.300.000 14.5%
2000 504.313.000 39.26%
2001 1.112.345.000 54.66%
2002 1.123.819.000 1.02%
2003 1.285.917.000 12.61%
2004 1.419.694.000 9.42%
2005 1.546.016.000 8.17%
2006 1.808.663.000 14.52%
2007 1.744.356.000 -3.69%
2008 1.773.872.000 1.66%
2009 1.115.364.000 -59.04%
2010 1.591.224.000 29.91%
2011 1.613.271.000 1.37%
2012 1.612.021.000 -0.08%
2013 1.651.030.000 2.36%
2014 1.789.441.000 7.73%
2015 1.917.810.000 6.69%
2016 1.877.794.000 -2.13%
2017 1.705.310.000 -10.11%
2018 1.855.773.000 8.11%
2019 1.750.360.000 -6.02%
2020 2.676.466.000 34.6%
2021 2.876.590.000 6.96%
2022 2.830.115.000 -1.64%
2023 2.858.721.000 1%

Amdocs Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
41.39
Net Income per Share
4.58
Price to Earning Ratio
20.04x
Price To Sales Ratio
2.2x
POCF Ratio
13.17
PFCF Ratio
15.37
Price to Book Ratio
3.08
EV to Sales
2.25
EV Over EBITDA
11.97
EV to Operating CashFlow
13.39
EV to FreeCashFlow
15.78
Earnings Yield
0.05
FreeCashFlow Yield
0.07
Market Cap
10,73 Bil.
Enterprise Value
11,02 Bil.
Graham Number
55.45
Graham NetNet
-11.92

Income Statement Metrics

Net Income per Share
4.58
Income Quality
1.52
ROE
0.15
Return On Assets
0.09
Return On Capital Employed
0.14
Net Income per EBT
0.84
EBT Per Ebit
0.97
Ebit per Revenue
0.14
Effective Tax Rate
0.16

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.08
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.35
Operating Profit Margin
0.14
Pretax Profit Margin
0.13
Net Profit Margin
0.11

Dividends

Dividend Yield
0.02
Dividend Yield %
1.9
Payout Ratio
0.37
Dividend Per Share
1.74

Operating Metrics

Operating Cashflow per Share
6.97
Free CashFlow per Share
5.91
Capex to Operating CashFlow
-0.15
Capex to Revenue
-0.03
Capex to Depreciation
-0.64
Return on Invested Capital
0.12
Return on Tangible Assets
0.15
Days Sales Outstanding
70.53
Days Payables Outstanding
33.88
Days of Inventory on Hand
0
Receivables Turnover
5.17
Payables Turnover
10.77
Inventory Turnover
0
Capex per Share
-1.05

Balance Sheet

Cash per Share
6,29
Book Value per Share
29,84
Tangible Book Value per Share
5.39
Shareholders Equity per Share
29.84
Interest Debt per Share
6.95
Debt to Equity
0.23
Debt to Assets
0.13
Net Debt to EBITDA
0.31
Current Ratio
1.41
Tangible Asset Value
0,64 Bil.
Net Current Asset Value
-0,95 Bil.
Invested Capital
0.23
Working Capital
0,56 Bil.
Intangibles to Total Assets
0.46
Average Receivables
1,01 Bil.
Average Payables
0,29 Bil.
Average Inventory
0
Debt to Market Cap
0.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Amdocs Limited Dividends
Year Dividends Growth
2012 0
2013 1 0%
2014 1 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 100%
2019 1 0%
2020 1 0%
2021 1 0%
2022 2 0%
2023 2 0%

Amdocs Limited Profile

About Amdocs Limited

Amdocs Limited, through its subsidiaries, provides software and services worldwide. The company designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. It provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; the Commerce and Care suite for order capture, handling, and customer engagement; the Monetization suite for charging, billing, policy, and revenue management; Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native business ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers; and eSIM Cloud for service providers. It also offers AI-powered, cloud-native, and home operating systems; data intelligence solutions and applications; media services for media publishers, TV networks, and video streaming and service providers; end-to-end application development and maintenance services; and ongoing services. In addition, the company provides a line of services designed for various stages of a service provider's lifecycle includes design, delivery, quality engineering, operations, systems integration, mobile network services, consulting, and content services; managed services comprising application development, modernization and maintenance, IT and infrastructure services, testing and professional services that are designed to assist customers in the selection, implementation, operation, management, and maintenance of IT systems. It serves to the communications, cable and satellite, entertainment, and media industry service providers, as well as mobile virtual network operators and directory publishers. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri.

CEO
Mr. Joshua Sheffer
Employee
29.000
Address
625 Maryville Centre Drive
Saint Louis, 63141

Amdocs Limited Executives & BODs

Amdocs Limited Executives & BODs
# Name Age
1 Mr. Avishai Sharlin
GM & Division President
70
2 Mustafa Oyumi
Head of B2B Strategy
70
3 Idit Duvdevany Aronsohn
Head of Corporate Responsibility, Inclusion & Wellbeing
70
4 Mr. Joshua Sheffer
President, Chief Executive Officer & Director
70
5 Anthony Goonetilleke
Group President of Technology & Head of Strategy
70
6 Mr. Matthew E. Smith
Secretary & Head of Investor Relations
70
7 Mr. Rajat Raheja
Division President of Amdocs Development Centre India LLP
70
8 Ms. Tamar Rapaport-Dagim
Chief Financial Officer & Chief Operating Officer
70

Amdocs Limited Competitors